Digital therapeutics market growth is propelled by a dramatic rise in chronic diseases and urgent need for innovative and scalable treatment solutions.New Delhi, Feb. 05, 2025 (GLOBE NEWSWIRE) -- The ...

We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...

We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...

A research team has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.

Halozyme Therapeutics, Inc. (NASDAQ:HALO) is a biopharmaceutical company focused on innovative drug delivery technologies, primarily through its Enhaze platform. This technology, based on the rHuPH20 ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal 2025 first quarter ended December 31, 2024. The Company is hosting ...

While some of the initial zeal around localized vaccine production in Africa has waned since the height of the COVID-19 pandemic, efforts to bolster the continent’s immunization autonomy—especially | ...

Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

President Donald Trump's effort to unilaterally wind down the United States Agency for International Development (USAID) has ...

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...